Abstract: An implantable or wearable lens for ophthalmic use, having a front surface and a rear surface, wherein at least one surface of said front surface and rear surface has an aspherical refractive profile with circular or rotational symmetry, or with cylindrical or non-rotational symmetry, with respect to the optical axis, and having a geometric elevation z(r) defined by a series expansion of Forbes polynomials, wherein said refractive profile generates an enhancement of the wavefront W(r) emerging from the lens such as to extend the depth of field thereof progressively and continuously in a power range between ?1.0 D and 4.0 D.

Abstract: The present invention relates to a sterile buffered eye topical composition containing metabolites of the fermentation of Lactobacillus pertaining to the species casei or paracasei and for ophthalmic use of the composition in the prevention or treatment of microbial eye infections, eye allergies, vernal keratoconjunctivitis and keratoconjunctivitis sicca and blepharitis.

Abstract: A lens for correcting astigmatism, possibly of ocular type, shaped so as to reduce the aberrations caused by accidental displacements with respect to the ideal correction position, in particular so as to ensure satisfactory performance even when rotated with respect to the ideal axis thereof.

Abstract: A lens for correcting astigmatism, possibly of ocular type, shaped so as to reduce the aberrations caused by accidental displacements with respect to the ideal correction position, in particular so as to ensure satisfactory performance even when rotated with respect to the ideal axis thereof.

Abstract: The present invention relates to a method for estimating the risk factor (HR) for the onset of macular degeneration in a subject, which method comprises the evaluation of a first series of genetic parameters comprising at least the genetic loci R1210C in CFH, variants in COL8A1 and RAD51 B, and the evaluation of a second series of environmental, individual and/or clinical parameters. This method is characterized in that said risk factor (HR) is calculated by assigning a greater importance to said evaluation of the first series of genetic parameters with respect to said evaluation of the second series of environmental, individual and/or clinical parameters. The method of the present invention thus allows to estimate the genetic risk of AMD more accurately than the methods known in the art.

Abstract: Methods and apparatus for an intraocular lens with a proofed surface are disclosed. The proofed surface functions as a barrier to fluid diffusion inside the material and within vacuoles. By preventing the interstitial filling of fluid, the formation of spots inside the polymer matrix is inhibited or reduced. The proofed surface of the intraocular lenses is a highly stable re-assembled surface without any coating or grafting.

Abstract: Methods and apparatus for an intraocular lens with a proofed surface are disclosed. The proofed surface functions as a barrier to fluid diffusion inside the material and within vacuoles. By preventing the interstitial filling of fluid, the formation of spots inside the polymer matrix is inhibited or reduced. The proofed surface of the intraocular lenses is a highly stable re-assembled surface without any coating or grafting.